Patients with severe COVID-19, as evidenced in our study, release a large amount of pro-inflammatory cytokines (IFN-α, IFN-γ, IL-1β, IL-6, IL-12, IL-18, IL-33, TNF- α, and TGF- β) [31]. This evidence concerns the gene IL33 and COVID-19.